Gaudium IVF Q4 FY26 Revenue ₹30 Cr, up 13%; PAT ₹8 Cr, up 30%

Gaudium IVF and Women Health Limited announced its audited financial results for Q4 and the full financial year ended March 31, 2026. For Q4 FY26, revenue from operations grew 12.74% YoY to ₹30.35 Cr, EBITDA increased 39.56% YoY to ₹12.17 Cr with a 40.10% margin, and PAT rose 29.46% YoY to ₹8.36 Cr with a 27.54% margin. For the full FY26, revenue surged 47.56% YoY to ₹104.35 Cr, EBITDA grew 31.69% YoY to ₹37.70 Cr (36.13% margin), and PAT increased 27.69% YoY to ₹24.48 Cr (23.47% margin). The growth was driven by higher patient volumes, clinical success rates, and operating leverage. The company also integrated AI-led embryology in April 2026 and plans to operationalize 3 new IVF hubs soon.